SK Biopharmaceuticals Co., Ltd. (KRX:326030)
South Korea · Delayed Price · Currency is KRW 101,000
-1,800 (-1.75%)
At close: Oct 17, 2025
SK Biopharmaceuticals Market Cap
SK Biopharmaceuticals has a market cap or net worth of 7.91 trillion as of October 17, 2025. Its market cap has decreased by -2.13% in one year.
Market Cap
7.91T
Enterprise Value
7.78T
Revenue
620.28B
Ranking
n/a
PE Ratio
30.90
Stock Price
101,000.00
Market Cap Chart
Since July 2, 2020, SK Biopharmaceuticals's market cap has decreased from 9.95T to 7.91T, a decrease of -20.47%. That is a compound annual growth rate of -4.23%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Oct 17, 2025 | 7,909.64B | -9.09% |
| Dec 30, 2024 | 8,700.60B | 10.66% |
| Dec 28, 2023 | 7,862.65B | 39.25% |
| Dec 29, 2022 | 5,646.39B | -25.82% |
| Dec 30, 2021 | 7,612.05B | -42.49% |
| Dec 30, 2020 | 13.23T | 33.07% |
| Jul 2, 2020 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Samsung Biologics | 79.50T |
| Celltrion | 38.55T |
| ALTEOGEN | 23.16T |
| Yuhan | 8,731.52B |
| Peptron | 5,910.95B |
| PharmaResearch | 5,735.09B |
| HLB Co., Ltd. | 5,221.68B |
| LigaChem Biosciences | 4,791.80B |